Category - Executive Moves

Executive Moves

Justin Zelin joins BTIG as biotech analyst

Justin Zelin BTIG has expanded its healthcare research coverage, adding Justin Zelin to its research and strategy division as a director. His biotech research coverage will include cell therapy, targeted oncology...

January 15, 2021

Executive Moves

IntelGenx names Tommy Kenny as VP of intellectual property and legal affairs, general counsel

Tommy Kenny IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) appointed Tommy Kenny as VP intellectual property and legal affairs, general counsel of IntelGenx Corp., the company’s operating subsidiary. Mr. Kenny has been...

January 13, 2021

Executive Moves

Fibrocor Therapeutics names biotech veteran Joseph Walewicz as CFO

Joseph Walewicz Closely-held Fibrocor Therapeutics appointed Joseph Walewicz, a biotech veteran with more than 25 years of experience in finance, capital markets and business development, as CFO. Prior to joining...

January 7, 2021

Executive Moves

iBio names renowned drug discovery and development expert Martin Brenner as CSO

Martin Brenner iBio (NYSE American:IBIO) appointed Martin Brenner, Doctor of Veterinary Medicine, Ph.D., as chief scientific officer, effective Jan. 18, 2021. Dr. Brenner has a strong history of success heading drug...

December 28, 2020

Executive Moves

PDS Biotechnology names Seth Van Voorhees as CFO

Seth Van Voorhees PDS Biotechnology (NASDAQ:PDSB) appointed Seth Van Voorhees, Ph.D., as its new CFO, effective Jan. 1, 2021. He replaces Michael King, who served as interim CFO. Dr. Van Voorhees most recently was CFO...

December 9, 2020

Executive Moves

Benjamin Bowen joins Roth’s healthcare investment banking team

Benjamin Bowen Benjamin Bowen, Ph.D., has joined Roth Capital Partners as managing director, healthcare investment banking. Prior to joining Roth, Dr. Bowen most recently was managing director in the investment banking...

December 4, 2020

Executive Moves

Profound Medical appoints accomplished financial executive, Murielle Lortie, to board

Murielle Lortie Profound Medical (NASDAQ:PROF; TSX:PRN) appointed financial executive, Murielle Lortie, as a director, effective immediately. Ms. Lortie is the CFO of Liminal Biosciences, a Nasdaq-listed, clinical-stage...

November 30, 2020

Executive Moves

ObsEva names Brian O’Callaghan as CEO

Brian O’Callaghan ObsEva (NASDAQ:OBSV) appointed Brian O’Callaghan as CEO, effective Dec. 1. He succeeds ObsEva’s co-founder, Ernest Loumaye, M.D., Ph.D., who is retiring from his role as CEO but will remain a...

November 9, 2020

Executive Moves

Marizyme names Neil Campbell as president and CEO

Marizyme (NASDAQ:MRZM) appointed Neil Campbell, Ph.D., as CEO, replacing executive chairman James Sapirstein, who has been the company’s interim CEO since September 2020. Dr. Campbell currently serves as chairman of...

November 6, 2020

Executive Moves

LogicBio names Mariana Nacht as CSO; Kyle Chiang as COO

LogicBio Therapeutics (NASDAQ:LOGC) appointed Mariana Nacht, Ph.D., as CSO, effective Nov. 30; and promoted Kyle Chiang, Ph.D., to the role of COO, effective Nov. 2. The company is expanding its leadership team to...

November 3, 2020

Category - Executive Moves

Justin Zelin joins BTIG as biotech analyst

IntelGenx names Tommy Kenny as VP of intellectual property and legal affairs, general counsel

Fibrocor Therapeutics names biotech veteran Joseph Walewicz as CFO

iBio names renowned drug discovery and development expert Martin Brenner as CSO

PDS Biotechnology names Seth Van Voorhees as CFO

Benjamin Bowen joins Roth’s healthcare investment banking team

Profound Medical appoints accomplished financial executive, Murielle Lortie, to board

ObsEva names Brian O’Callaghan as CEO

Marizyme names Neil Campbell as president and CEO

LogicBio names Mariana Nacht as CSO; Kyle Chiang as COO

General

More